Series A - Amyl Therapeutics
Investment Firm
Overview
Amyl Therapeutics is a preclinical stage biotechnology company.
Announced Date
Nov 07, 2023
Funding Type
Series A
Highlights
Location
Europe
Social
Investor Lead
N/A
Participant Investors
3
| Investor Name |
|---|
 Meusinvest (Noshaq) |
 Evren Ucok |
Round Details and Background
Amyl Therapeutics raised $5669225 on 2023-11-07 in Series A
Amyl Therapeutics is a preclinical stage biotechnology company.
Company Funding History
4
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jun 03, 2021 |  Series A - Amyl Therapeutics | 7 | - | 10.4M |
| Jun 03, 2021 | Grant - Amyl Therapeutics | 1 | - | 11.8M |
| Nov 07, 2023 | Grant - Amyl Therapeutics | - | 6.5M | |
| Nov 07, 2023 | Series A - Amyl Therapeutics | 3 | - | 5.7M |
Recent Activity
There is no recent news or activity for this profile.